Strand Analytical Laboratories began shifting its focus after a company official saw a news report about a Boston man who had unnecessary prostate surgery after his biopsy was switched with that of a man who had cancer. Chief financial officer Travis Morgan says about 6 percent of all prostate biopsies and 1 percent of all breast biopsies use the Know Error system.